Erythrocyte Sedimentation Rate and C-Reactive Protein: How Best to Use Them in Clinical Practice
Abstract
Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) are markers of inflammatory conditions and have been used extensively by clinicians both in outpatient and inpatient settings. It is important to understand the physiologic principles behind these two tests so clinicians may use them appropriately. For example, fibrinogen (for which ESR is an indirect measure) has a much longer half-life than CRP, making ESR helpful in monitoring chronic inflammatory conditions, whereas CRP is more useful in diagnosis as well as in monitoring responses to therapy in acute inflammatory conditions, such as acute infections. Many factors can result in falsely high or low ESR and CRP levels, and it is important to take note of these. Therefore, if used wisely, ESR and CRP can be complementary to good history taking and physical examination in the diagnosis and monitoring of inflammatory conditions. [Pediatr Ann. 2014;43(10):417–420.]
- 1.Brigden ML. Clinical utility of the erythrocyte sedimentation rate. Am Fam Physician. 1999; 60(5):1443–1450. > MedlineGoogle Scholar
- 2.Grzybowski A, Sak JJ. Who discovered the erythrocyte sedimentation rate?J Rheumatol. 2011; 38(7):1521–1522; author reply 1523.
10.3899/jrheum.101312 > Crossref MedlineGoogle Scholar - 3.Janson LW, Tischler M. The Big Picture: Medical Biochemistry. New York, NY: McGraw-Hill; 2012. > Google Scholar
- 4.Batlivala SP. Focus on diagnosis: the erythrocyte sedimentation rate and the C-reactive protein test. Pediatr Rev. 2009; 30(2):72–74.
10.1542/pir.30-2-72 > Crossref MedlineGoogle Scholar - 5.Husain TM, Kim DH, C-reactive protein and erythrocyte sedimentation rate in orthopaedics. Univ Pennsylvania Orthop J. 2002; 15:13–16. > Google Scholar
- 6.Wilson DA. Immunologic tests. In: , eds. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd ed. Boston, MA: Butterworth-Heineman; 1990. > Google Scholar
- 7.Isenman DE, Mandle R, Carroll MC. Complement and immunoglobulin biology. In: , eds. Hematology: Basic Principles and Practice. 6th ed. Philadelphia, PA: Elsevier Saunders; 2013:228–246.e4. > Google Scholar
- 8.Kamath S, Lip GYH. Fibrinogen: biochemistry, epidemiology and determinants. QJM. 2003; 96(10):711–729.
10.1093/qjmed/hcg129 > Crossref MedlineGoogle Scholar - 9.Newburger JW, Takahashi M, Gerber MA, ; Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics. 2004; 114(6):1708–1733.
10.1542/peds.2004-2182 > Crossref MedlineGoogle Scholar - 10.Nimmerjahn F, Ravetch JV. The antiinflammatory activity of IgG: the intravenous IgG paradox. J Exp Med. 2007; 204(1):11–15.
10.1084/jem.20061788 > Crossref MedlineGoogle Scholar - 11.Salehzadeh F, Noshin A, Jahangiri S. IVIg effects on erythrocyte sedimentation rate in children. Int J Pediatr. 2014; 2014:981465.
10.1155/2014/981465 > Crossref MedlineGoogle Scholar - 12.Vermeire S, Van Assche G, Rutgeerts P. C-reactive protein as a marker for inflammatory bowel disease. Inflamm Bowel Dis. 2004; 10(5):661–665.
10.1097/00054725-200409000-00026 > Crossref MedlineGoogle Scholar - 13.Nudelman R, Kagan BM. C-reactive protein in pediatrics. Adv Pediatr. 1983; 30:517–547. > MedlineGoogle Scholar
- 14.Jaye DL, Waites KB. Clinical applications of C-reactive protein in pediatrics. Pediatr Infect Dis J. 1997; 16(8):735–746; quiz 746–747.
10.1097/00006454-199708000-00003 > Crossref MedlineGoogle Scholar - 15.Koenig W. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy. Int J Cardiol. 2013; 168(6):5126–5134.
10.1016/j.ijcard.2013.07.113 > Crossref MedlineGoogle Scholar - 16.Silvestre JP, Coelho LM, Povoa PM. Impact of fulminant hepatic failure in C-reactive protein?J Crit Care. 2010; 25(4):657.e7–12.
10.1016/j.jcrc.2010.02.004 > Crossref MedlineGoogle Scholar - 17.Benitz WE, Han MY, Madan A, Ramachandra P. Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics. 1998; 102(4):e41.
10.1542/peds.102.4.e41 > Crossref MedlineGoogle Scholar - 18.Sanders S, Barnett A, Correa-Velez I, Coulthard M, Doust J, Systematic review of the diagnostic accuracy of C-reactive protein to detect bacterial infection in nonhospitalized infants and children with fever. J Pediatr. 2008; 153(4):570–574.
10.1016/j.jpeds.2008.04.023 > Crossref MedlineGoogle Scholar - 19.Paakkonen M, Kallio MJ, Kallio PE, Peltola H. Sensitivity of erythrocyte sedimentation rate and C-reactive protein in childhood bone and joint infections. Clin Orthop Relat Res. 2010; 468(3):861–866.
10.1007/s11999-009-0936-1 > Crossref MedlineGoogle Scholar - 20.Reitzenstein JE, Yamamoto LG, Mavoori H. Similar erythrocyte sedimentation rate and C-reactive protein sensitivities at the onset of septic arthritis, osteomyelitis, acute rheumatic fever. Pediatr Rep. 2010; 2(1):e10. > MedlineGoogle Scholar
- 21.Unkila-Kallio L, Kallio MJ, Eskola J, Peltola H. Serum C-reactive protein, erythrocyte sedimentation rate, and white blood cell count in acute hematogenous osteomyelitis of children. Pediatrics. 1994; 93(1):59–62. > Crossref MedlineGoogle Scholar
- 22.Vermeire S, Van Assche G, Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys?Gut. 2006; 55(3):426–431.
10.1136/gut.2005.069476 > Crossref MedlineGoogle Scholar - 23.Turner D, Mack DR, Hyams J, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) or both? A systematic evaluation in pediatric ulcerative colitis. J Crohns Colitis. 2011; 5(5):423–429.
10.1016/j.crohns.2011.05.003 > Crossref MedlineGoogle Scholar - 24.Barland P, Lipstein E. Selection and use of laboratory tests in the rheumatic diseases. Am J Med. 1996; 100(2A):16S–23S.
10.1016/S0002-9343(97)89542-3 > Crossref MedlineGoogle Scholar - 25.Fernando MM, Isenberg DA. How to monitor SLE in routine clinical practice. Ann Rheum Dis. 2005; 64(4):524–527.
10.1136/ard.2003.015248 > Crossref MedlineGoogle Scholar - 26.Gaitonde S, Samols D, Kushner I. C-reactive protein and systemic lupus erythematosus. Arthritis Care Res. 2008; 59(12):1814–1820.
10.1002/art.24316 > CrossrefGoogle Scholar - 27.Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003; 111(12):1805–1812.
10.1172/JCI200318921 > Crossref MedlineGoogle Scholar